(SAN MATEO, Calif.)IScribe, Inc., a provider of electronic, hand-held prescription-writing systems for doctors, is expected to announce a joint-market deal with pharmaceutical giant Johnson & Johnson. The Johnson & Johnson sales force will promote iScribe to primary-care doctors and specialists. In exchange, Johnson & Johnson will obtain the right to sponsor advertising and health information on the system. This will include Johnson & Johnson paying a sponsorship fee that will be determined by the number of physicians using the iScribe system. For more information visit www.iscribe.com.
The Value of Certification in Infection Prevention and Control: Why Is it important?
May 14th 2024Certification in infection prevention and control is essential for career growth, higher salaries, and improved patient outcomes. Learn why certification matters from Shazia Irum, MSC, MBA, RN, CIC, CPHQ, CBIC Ambassador in Saudi Arabia.